Advertisement
Research Article| Volume 7, ISSUE 3, P499-512, September 1987

Download started.

Ok

Antimicrobial Susceptibility Tests and Their Role in Therapeutic Drug Monitoring

  • Paola C. DeGirolami
    Correspondence
    Corresponding author: Department of Pathology, New England Deaconess Hospital, 185 Pilgrim Road, Boston, Massachusetts 02215
    Affiliations
    Assistant Professor, Department of Pathology, Harvard Medical School, and Director of Microbiology, New England Deaconess Hospital, Boston, Massachusetts
    Search for articles by this author
  • George Eliopoulos
    Affiliations
    Assistant Professor, Department of Medicine, Harvard Medical School, and Assistant Chairman, Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30726-1
Antimicrobial Susceptibility Tests and Their Role in Therapeutic Drug Monitoring
Previous ArticlePreface
Next ArticleMonitoring Aminoglycoside Therapy
      This paper is only available as a PDF. To read, Please Download here.
      Principles and techniques of routine and special in vitro antimicrobial susceptibility testing of bacteria are reviewed with emphasis on the advantages, limitations, and potential problems of each method. The utilities of MBC testing and of serum bactericidal titer determination are discussed in the clinical context. The use of testing for possible antibiotic interactions is examined in light of potential benefits and risks of combination antimicrobial therapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Allan J.D.
        • Moellering Jr, R.C.
        Management of infections caused by gram-negative bacilli: The role of antimicrobial combinations.
        Rev Infect Dis. 1985; 7: S559-S571
        • Baker C.N.
        • Stocker S.A.
        • Rhoden D.L.
        • Thornsberry C.
        Evaluation of the MicroScan antimicrobial susceptibility system with the AutoScan-4 automated reader.
        J Clin Microbiol. 1986; 23: 143-148
        • Barry A.L.
        • Badal R.E.
        Reliability of the microdilution technic for detection of methicillin-resistant strains of Staphylococcus aureus.
        Am J Clin Pathol. 1977; 67: 489-495
        • Barry A.L.
        • Jones R.N.
        • Gavan T.L.
        Evaluation of the Micro-Media System for quantitative antimicrobial drug susceptibility testing: A collaborative study.
        Antimicrob Agents Chemother. 1978; 13: 61-69
        • Blenkharn J.I.
        • Habib N.
        • Mok D.
        • et al.
        Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice.
        Antimicrob Agents Chemother. 1985; 28: 778-780
        • Boyce J.M.
        • Lytle L.S.
        • Walsh D.A.
        Detection of methicillin-resistant Staphylococcus aureus by microdilution and disk elution susceptibility systems.
        J Clin Microbiol. 1984; 20: 1068-1075
        • Calderwood S.B.
        • Wennersten C.
        • Moellering Jr, R.C.
        Resistance to antibiotic synergism in Streptococcus faecalis: Further studies with amikacin and with a new amikacin derivative, 4’-deoxy-6’N-methylamikacin.
        Antimicrob Agents Chemother. 1981; 19: 549-555
        • DeGirolami P.C.
        • Eichelberger K.A.
        • Salfity L.C.
        • Rizzo M.F.
        Evaluation of the Auto Scan-3, a device for reading microdilution trays.
        J Clin Microbiol. 1983; 18: 1292-1295
        • Eliopoulos G.M.
        • Moellering Jr, R.C.
        Principles of antibiotic therapy.
        Med Clin North Am. 1982; 66: 3-24
        • Eliopoulos G.M.
        • Moellering Jr, R.C.
        Antibiotic synergism and antimicrobial combinations in clinical infections.
        Rev Infect Dis. 1982; 4: 282-293
        • Emerson B.B.
        • Smith A.L.
        • Harding A.L.
        • Smith D.H.
        Haemophilus influenzae type B susceptibility of seventeen antibiotics.
        Pediatrics. 1975; 86: 617-620
        • Ericsson H.M.
        • Sherris J.C.
        Antibiotic sensitivity testing—report of an international collaborative study.
        Acta Pathol Microbiol Scand Sect B Suppl. 1971; 217: 3-90
        • Farber B.F.
        • Eliopoulos G.M.
        • Ward J.I.
        • et al.
        Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococci.
        Antimicrob Agents Chemother. 1983; 24: 871-875
        • Fisher A.M.
        A method for the determination of antibacterial potency of serum during therapy of acute infections: A preliminary report.
        Bull Johns Hopkins Hosp. 1952; 90: 313-320
        • Gerlach E.H.
        Microdilution: I. A comparative study.
        in: Balows A. Current Techniques for Antibiotic Susceptibility Testing. Charles C Thomas, Springfield, Illinois1974: 63-76
        • Gerlach E.H.
        Dilution test procedures for susceptibility testing.
        in: Bondi A. Bartola J.T. Prier J.D. The Clinical Laboratory as an Aid in Chemotherapy of Infectious Disease. University Park Press, Baltimore1977: 45-50
        • Goessens W.H.F.
        • Fontijne P.
        • Michel M.F.
        Factors influencing detection of tolerance in Staphylococcus aureus.
        Antimicrob Agents Chemother. 1982; 22: 364-368
        • Gootz T.D.
        • Sanders C.C.
        • Goering R.V.
        Resistance to cefamandole: Depression of β-lactamases by cefoxitin and mutation in Enterobacter cloacae.
        J Infect Dis. 1982; 146: 34-42
        • Gribble M.J.
        • Chow A.W.
        • Naiman S.C.
        • et al.
        Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections.
        Antimicrob Agents Chemother. 1983; 24: 388-393
        • Handwerger S.
        • Tomasz A.
        Antibiotic tolerance among clinical isolates of bacteria.
        Rev Infect Dis. 1986; 7: 368-386
        • Hauser Jr, W.E.
        • Remington J.S.
        Effect of antibiotics on the immune response.
        Am J Med. 1982; 72: 711-716
        • Jones R.N.
        • Barry A.L.B.
        • Gavan T.L.
        • Washington II, J.A.
        Susceptibility tests: Microdilution and macrodilution broth procedures.
        in: Lennette E.H. Manual of Clinical Microbiology. Edition 4. American Society for Microbiology, Washington1985: 972-977
        • Jones R.N.
        • Gavan T.L.
        • Barry A.L.
        Evaluation of the Sensititre microdilution antibiotic susceptibility system against recent clinical isolates: Three-laboratory collaborative study.
        J Clin Microbiol. 1980; 11: 426-429
        • Jones R.N.
        • Thornsberry C.
        • Barry A.L.
        • Gavan T.L.
        Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: A collaborative investigation.
        J Clin Microbiol. 1981; 13: 184-194
        • Jorgensen J.H.
        • Lee J.C.
        • Jones P.M.
        Chemically defined antimicrobial susceptibility test medium for Pseudomonas aeruginosa.
        Antimicrob Agents Chemother. 1977; 11: 415-419
        • Klastersky J.
        • Hensgens C.
        • Meunier-Carpentier F.
        Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: Double-blind clinical trial.
        J Infect Dis. 1976; 134: S433-S440
        • Korzeniowski O.
        • Sande M.A.
        • The National Collaborative Endocarditis Study Group
        Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts.
        Ann Intern Med. 1982; 97: 496-503
        • Krogstad D.J.
        • Moellering R.C.
        Antimicrobial combinations.
        in: Lorian V. Antibiotics in Laboratory Medicine. Williams & Wilkins, Baltimore1986: 537-595
        • Kunin C.M.
        • Chambers S.
        Responsibility of the infectious disease community for optimal use of antibiotics: Views of the membership of the Infectious Disease Society of America.
        Rev Infect Dis. 1985; 7: 547-559
        • Medical Letter
        New drugs for enteric gram-negative bacillary meningitis in adults.
        Med Lett. 1981; 23: 73-74
        • Moellering Jr, R.C.
        • Watson B.K.
        • Kunz L.J.
        Endocarditis due to group D streptococci.
        Am J Med. 1974; 57: 239-250
        • Moellering Jr, R.C.
        • Willey S.
        • Eliopoulos G.M.
        Synergism and antagonism of ceftizoxime and other new cephalosporins.
        J Antimicrob Chemother. 1982; 10: 69-79
      33. National Committee for Clinical Laboratory Standards. Approved standard M7-A. Methods for dilution: Antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS, Villanova, Pennsylvania1985
      34. National Committee for Clinical Laboratory Standards. Approved standard M11-A. Reference agar dilution procedure for antimicrobial susceptibility testing of anaerobic bacteria. NCCLS, Villanova, Pennsylvania1984
      35. National Committee for Clinical Laboratory Standards. Approved standard M2-A3. Performance standards for antimicrobial disk susceptibility tests. NCCLS, Villanova, Pennsylvania1984
        • Neu H.C.
        Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death.
        Am J Med. 1983; 75: 9-20

      37. Neu HC: The effects of cations upon the activity of quinolone agents. Quinolones Bull, Apr 1, 1985

        • Parrillo J.E.
        • Borst G.C.
        • Mazur M.H.
        • et al.
        Endocarditis due to resistant viridans streptococci during oral penicillin chemoprophylaxis.
        N Engl J Med. 1979; 300: 296-300
        • Pearson R.D.
        • Steigbigel R.T.
        • Davis H.T.
        • Chapman S.W.
        Method for reliable determination of minimal lethal antibiotic concentrations.
        Antimicrob Agents Chemother. 1980; 18: 699-708
        • Reller L.B.
        The serum bactericidal test.
        Rev Infect Dis. 1986; 8: 803-808
        • Reller L.B.
        • Stratton C.W.
        Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests.
        J Infect Dis. 1977; 136: 196-204
        • Ryan R.W.
        • Kasasnik I.
        • Tilton R.C.
        Methodological variation in antibiotic synergy tests against enterococci.
        J Clin Microbiol. 1981; 13: 73-75
        • Sabath L.D.
        • Wheeler N.
        • Laverdiere M.
        • et al.
        A new type of penicillin resistance of Staphylococcus aureus.
        Lancet. 1977; 1: 443-447
        • Sande M.A.
        • Scheid W.M.
        Combination antibiotic therapy of bacterial endocarditis.
        Ann Intern Med. 1980; 92: 390-395
        • Sanders S.J.
        • Gavan T.L.
        • Senturia J.B.
        • Smeby R.R.
        Serum bactericidal testing with the Autobac System.
        J Clin Microbiol. 1986; 24: 435-439
        • Schimpff S.C.
        • Drusano G.L.
        • Standiford H.C.
        Serum bactericidal test in volunteers—a review.
        Eur J Clin Microbiol. 1986; 5: 71-78
        • Schlichter J.G.
        • MacLean H.
        A method of determining the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin: A preliminary report.
        Am Heart J. 1947; 34: 209-211
        • Schoenknecht F.D.
        • Sabath L.D.
        • Thornsberry C.
        Susceptibility tests: Special test.
        in: Lennette E.H. Manual of Clinical Microbiology. Edition 4. American Society for Microbiology, Washington1985: 1000-1008
        • Schoenknecht F.D.
        • Washington II, J.A.
        • Gavan T.L.
        • Thornsberry C.
        Rapid determination of minimum inhibitory concentrations of antimicrobial agents by the Autobac method: A collaborative study.
        Antimicrob Agents Chemother. 1980; 17: 824-833
        • Sculier J.P.
        • Klastersky J.
        Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia.
        Am J Med. 1984; 76: 429-435
        • Shanholtzer C.J.
        • Peterson L.R.
        • Mohn M.L.
        • et al.
        MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.
        Antimicrob Agents Chemother. 1984; 26: 214-219
        • Stratton C.W.
        • Reller L.B.
        Serum dilution test for bactericidal activity I. Selection of physiologic diluent.
        J Infect Dis. 1977; 136: 187-195
        • Syriopoulou V.
        • Scheifele D.W.
        • Sack C.M.
        • Smith A.L.
        Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics.
        Antimicrob Agents Chemother. 1979; 16: 510-513
        • Taylor P.C.
        • Schoenknecht F.D.
        • Sherris J.C.
        • Linner E.C.
        Determination of minimum bactericidal concentrations of oxacillin for Straphylococcus aureus: Influence and significance of technical factors.
        Antimicrob Agents Chemother. 1983; 23: 142-150
        • Thornsberry C.
        • Anhalt J.P.
        • Washington II, J.A.
        • et al.
        Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: Report of a collaborative study.
        J Clin Microbiol. 1980; 12: 375-390
        • Thrupp L.D.
        Susceptibility testing of antibiotics in liquid media.
        in: Lorian V. Antibiotics in Laboratory Medicine. Edition 2. Williams & Wilkins, Baltimore1986: 91-150
        • Tilton R.C.
        • Newberg L.
        Standardization of the microdilution susceptibility test.
        in: Balows A. Current Techniques for Antibiotic Susceptibility Testing. Charles C Thomas, Springfield, Illinois1973: 77-87
        • Weinstein M.P.
        • Stratton C.W.
        • Ackley A.
        • et al.
        Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis.
        Am J Med. 1985; 78: 262-269
        • Wolfson J.S.
        • Swartz M.N.
        Serum bactericidal activity as a monitor of antibiotic therapy.
        N Engl J Med. 1985; 312: 968-975
        • Woolfrey B.F.
        • Lally R.T.
        • Ederer M.N.
        Evaluation of the AutoMicrobic system grampositive susceptibility-MIC card for detection of oxacillin-resistant coagulase-negative staphylococci.
        J Clin Microbiol. 1986; 23: 629-630
        • Woolfrey B.F.
        • Lally R.T.
        • Ederer M.N.
        • Quail C.O.
        Evaluation of the AutoMicrobic system for identification and susceptibility testing of gram-negative bacilli.
        J Clin Microbiol. 1984; 20: 1053-1059
        • Woolfrey B.F.
        • Lally R.T.
        • Tait K.R.
        Influence of technical factor variations on serum inhibition and bactericidal titers.
        J Clin Microbiol. 1986; 23: 997-1000
        • Zimmerman R.A.
        • Moellering Jr, R.C.
        • Weinberg A.N.
        Mechanism of resistance to antibiotic synergism in enterococci.
        J Bacteriol. 1971; 105: 873-879

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30726-1

      Copyright

      © 1987 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX